Abstract CT097: First report of preliminary safety, efficacy, and pharmacokinetics of C-CAR031 (GPC3-specific TGFβRIIDN CAR-T) in patients with advanced HCC

MLA

Qi Zhang, et al. “Abstract CT097: First Report of Preliminary Safety, Efficacy, and Pharmacokinetics of C-CAR031 (GPC3-Specific TGFβRIIDN CAR-T) in Patients with Advanced HCC.” Cancer Research, vol. 83, Apr. 2023, p. CT097. EBSCOhost, https://doi.org/10.1158/1538-7445.am2023-ct097.

APA

Qi Zhang, Qihan Fu, Wanyue Cao, Xingyuan Xu, Ao Xia, Jiaqi Huang, Andy Zou, Judy Zhu, Fei Wang, Yi Hong, Hui Wan, Yihong Yao, Nina Chu, Ryan Gilbreth, Maria Letizia Giardino Torchia, John Stone, Attilio Bondanza, Benny Farsaci, Gordon Moody, … Tingbo Liang. (2023). Abstract CT097: First report of preliminary safety, efficacy, and pharmacokinetics of C-CAR031 (GPC3-specific TGFβRIIDN CAR-T) in patients with advanced HCC. Cancer Research, 83, CT097. https://doi.org/10.1158/1538-7445.am2023-ct097

Chicago

Qi Zhang, Qihan Fu, Wanyue Cao, Xingyuan Xu, Ao Xia, Jiaqi Huang, Andy Zou, et al. 2023. “Abstract CT097: First Report of Preliminary Safety, Efficacy, and Pharmacokinetics of C-CAR031 (GPC3-Specific TGFβRIIDN CAR-T) in Patients with Advanced HCC.” Cancer Research 83 (April): CT097. doi:10.1158/1538-7445.am2023-ct097.